Citigroup provided a stock rating for Altimmune, Inc.
1 report, 1 independent
Updated Sep 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided a stock rating for Altimmune, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Altimmune, Inc.
American biopharmaceutical company
Nothing else this week.
Related events
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.
- Citigroup issued a market underperform rating for Hovnanian Enterprises, Inc. on October 22, 2026.
- Citigroup and Morgan Stanley provided price target and rating updates for Altria on November 4, 2026.